X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
aged (23) 23
female (23) 23
male (23) 23
index medicus (22) 22
cardiac & cardiovascular systems (18) 18
middle aged (18) 18
aged, 80 and over (16) 16
mortality (14) 14
registries (14) 14
france - epidemiology (13) 13
cardiovascular (12) 12
treatment outcome (12) 12
cardiac patients (10) 10
france (10) 10
life sciences (10) 10
abridged index medicus (9) 9
heart attack (9) 9
myocardial infarction - mortality (9) 9
acute coronary syndromes (8) 8
care and treatment (8) 8
follow-up studies (8) 8
internal medicine (8) 8
management (8) 8
percutaneous coronary intervention (8) 8
prognosis (8) 8
prospective studies (8) 8
risk factors (8) 8
cardiology (7) 7
diagnosis (7) 7
electrocardiography (7) 7
guidelines (7) 7
heart attacks (7) 7
heart failure (7) 7
research (7) 7
myocardial infarction (6) 6
outcomes (6) 6
cohort studies (5) 5
heart failure - mortality (5) 5
heart failure - therapy (5) 5
hospital mortality (5) 5
impact (5) 5
myocardial infarction - therapy (5) 5
age factors (4) 4
analysis (4) 4
bioengineering (4) 4
cardiology and cardiovascular medicine (4) 4
cardiovascular disease (4) 4
care (4) 4
coronary vessels (4) 4
intensive-care units (4) 4
myocardial infarction - drug therapy (4) 4
patient outcomes (4) 4
preserved ejection fraction (4) 4
prevalence (4) 4
stroke volume (4) 4
survival rate - trends (4) 4
task-force (4) 4
time factors (4) 4
trends (4) 4
acute coronary syndrome - diagnosis (3) 3
acute myocardial infarction (3) 3
adrenergic beta-antagonists - therapeutic use (3) 3
adult (3) 3
cardiovascular agents - therapeutic use (3) 3
clinical-outcomes (3) 3
clopidogrel (3) 3
coronary angiography (3) 3
elderly (3) 3
european-society (3) 3
french registry (3) 3
health aspects (3) 3
hospitalization (3) 3
human health and pathology (3) 3
intervention (3) 3
medical research (3) 3
medicine, experimental (3) 3
medicine, general & internal (3) 3
metaanalysis (3) 3
myocardial infarction - complications (3) 3
myocardial infarction - epidemiology (3) 3
of-cardiology (3) 3
patients (3) 3
propensity score (3) 3
registry (3) 3
sex factors (3) 3
survival (3) 3
thrombolysis (3) 3
acute coronary syndrome (2) 2
acute coronary syndrome - therapy (2) 2
aged patients (2) 2
angiotensin receptor blockers (2) 2
angiotensin-converting enzyme inhibitors (2) 2
antagonistas de los receptores de la angiotensina ii (2) 2
antiplatelet therapy (2) 2
association (2) 2
base-line characteristics (2) 2
beta-blockers (2) 2
bloqueadores beta (2) 2
cardiac catheterization (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 112, Issue 3, pp. 336 - 342
Journal Article
Heart and Vessels, ISSN 0910-8327, 06/2017, Volume 32, Issue 6, pp. 735 - 749
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 08/2015, Volume 86, Issue 2, pp. E58 - E65
ObjectivesTo assess the impact of gender on myocardial revascularization using data collected in a French nationwide registry: the national observational study... 
myocardial revascularization | percutaneous coronary intervention | gender | Keys words: acute coronary syndrome | acute coronary syndrome | CARDIAC & CARDIOVASCULAR SYSTEMS | PRACTICE GUIDELINES | ACC/AHA GUIDELINES | ST-SEGMENT-ELEVATION | OF-CARDIOLOGY | ARRHYTHMIA PROFILE | LONG-TERM OUTCOMES | SINGLE VESSEL DISEASE | BASE-LINE CHARACTERISTICS | ASSOCIATION TASK-FORCE | ELEVATION MYOCARDIAL-INFARCTION | Multivariate Analysis | Predictive Value of Tests | Age Factors | Health Status Disparities | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Process Assessment (Health Care) - utilization | Acute Coronary Syndrome - mortality | Cardiac Catheterization - utilization | Male | Cardiac Catheterization - mortality | Coronary Artery Bypass - utilization | Coronary Artery Bypass - mortality | Percutaneous Coronary Intervention - utilization | Aged, 80 and over | Female | Registries | Coronary Angiography - utilization | France | Odds Ratio | Severity of Illness Index | Hospital Mortality | Risk Assessment | Risk Factors | Cardiac Catheterization - adverse effects | Logistic Models | Treatment Outcome | Chi-Square Distribution | Coronary Artery Bypass - adverse effects | Propensity Score | Acute Coronary Syndrome - diagnosis | Sex Factors | Healthcare Disparities | Acute Coronary Syndrome - therapy | Aged | Percutaneous Coronary Intervention - adverse effects | Index Medicus | Life Sciences | Bioengineering
Journal Article
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 4, pp. 365 - 373
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2017, Volume 130, Issue 5, pp. 555 - 563
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2011, Volume 108, Issue 6, pp. 755 - 759
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 8, pp. e19 - e19
  Background Growth hormone/insulin-like growth factor I (IGF-I) axis is being targeted for therapeutic development in diseases such as short stature, cancer,... 
Internal Medicine | Medical Education | PHARMACOLOGY & PHARMACY | Stroke | Insulin-like growth factors | Heart attacks | Insulin | Metabolic disorders
Journal Article
Circulation, ISSN 0009-7322, 02/2011, Volume 123, Issue 5, pp. 474 - 482
Background-Clopidogrel requires metabolic activation by cytochrome P450 2C19 (CYP2C19). Proton pump inhibitors (PPIs) that inhibit CYP2C19 are commonly... 
clopidogrel | mortality | proton pump inhibitors | platelet aggregation inhibitors | acute myocardial infarction | pharmacogenetics | LANSOPRAZOLE | CARDIAC & CARDIOVASCULAR SYSTEMS | OMEPRAZOLE | PHARMACODYNAMICS | ANTIPLATELET THERAPY | ATORVASTATIN | PANTOPRAZOLE | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | PHARMACOKINETICS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | DRUG-INTERACTION | France - epidemiology | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Ticlopidine - therapeutic use | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Genotype | Male | Treatment Outcome | Proton Pump Inhibitors - therapeutic use | Ticlopidine - analogs & derivatives | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Cytochrome P-450 CYP2C19 | Aged, 80 and over | Female | Registries | Aged | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Cohort Studies | Usage | Care and treatment | Physiological aspects | Proton pump inhibitors | Clopidogrel | Cytochromes | Genetic aspects | Research | Diagnosis | Heart attack | Index Medicus | Abridged Index Medicus | Proton Pump Inhibitors | Ticlopidine | Tissues and Organs | Life Sciences | Human health and pathology | Myocardial Infarction | Platelet Aggregation Inhibitors | Purinergic P2Y Receptor Antagonists | France | Aryl Hydrocarbon Hydroxylases
Journal Article
Archives of Cardiovascular Diseases, ISSN 1875-2136, 2013, Volume 107, Issue 1, pp. 21 - 32
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 04/2013, Volume 15, Issue 4, pp. 465 - 476
Journal Article